HealthEquity, Inc. $HQY Shares Sold by Faithward Advisors LLC

Faithward Advisors LLC trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,374 shares of the company’s stock after selling 10,206 shares during the quarter. Faithward Advisors LLC’s holdings in HealthEquity were worth $3,332,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Xponance Inc. boosted its holdings in HealthEquity by 0.8% during the third quarter. Xponance Inc. now owns 12,265 shares of the company’s stock worth $1,162,000 after buying an additional 102 shares in the last quarter. Truist Financial Corp lifted its holdings in shares of HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock valued at $232,000 after purchasing an additional 119 shares in the last quarter. Fiduciary Trust Co lifted its holdings in shares of HealthEquity by 3.4% in the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC lifted its holdings in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after purchasing an additional 123 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of HealthEquity by 9.5% in the fourth quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after purchasing an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on HQY shares. UBS Group set a $110.00 price target on shares of HealthEquity in a report on Tuesday, February 17th. Barclays cut their price objective on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. BTIG Research cut their price objective on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. Finally, Jefferies Financial Group set a $108.00 price objective on shares of HealthEquity in a research report on Thursday, February 19th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $110.57.

HealthEquity Trading Down 1.6%

NASDAQ HQY opened at $86.97 on Tuesday. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $106.60. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The company has a market capitalization of $7.27 billion, a price-to-earnings ratio of 32.57, a price-to-earnings-growth ratio of 1.49 and a beta of 0.21. The company’s fifty day moving average price is $84.69 and its two-hundred day moving average price is $85.62.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. This represents a 5.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 13,081 shares of company stock worth $1,193,000. 1.60% of the stock is currently owned by insiders.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.